These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20626523)

  • 21. Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia.
    Ohki R; Takahashi M; Mizuno O; Fujikawa H; Mitsuhashi T; Katsuki T; Ikeda U; Shimada K
    Pacing Clin Electrophysiol; 2001 Jan; 24(1):119-21. PubMed ID: 11227957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroenteritis with severe consequences: a case of sotalol-induced torsades de pointes.
    Michiels V; Miljoen H; Vrints C
    Acta Cardiol; 2009 Dec; 64(6):839-42. PubMed ID: 20128168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
    Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
    Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K; Dorian P
    Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.
    Hanley CM; Robinson VM; Kowey PR
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002479. PubMed ID: 26936819
    [No Abstract]   [Full Text] [Related]  

  • 26. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.
    Di Micoli A; Zambruni A; Bracci E; Benazzi B; Zappoli P; Berzigotti A; Zoli M; Bernardi M; Trevisani F
    Dig Liver Dis; 2009 Jul; 41(7):535-8. PubMed ID: 18294935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-atrial Fibrillatory Versus Proarrhythmic Potentials of Amiodarone: A New Protocol for Safety Evaluation In Vivo.
    Matsukura S; Nakamura Y; Cao X; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
    Cardiovasc Toxicol; 2017 Apr; 17(2):157-162. PubMed ID: 27040813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract]   [Full Text] [Related]  

  • 30. Amiodarone versus sotalol for atrial fibrillation.
    Zimetbaum PJ; Josephson ME
    N Engl J Med; 2005 Aug; 353(6):627-30; author reply 627-30. PubMed ID: 16094764
    [No Abstract]   [Full Text] [Related]  

  • 31. Opposing effects of bepridil on ventricular repolarization in humans. Inhomogeneous prolongation of the action potential duration vs flattening of its restitution kinetics.
    Osaka T; Yokoyama E; Kushiyama Y; Hasebe H; Kuroda Y; Suzuki T; Kodama I
    Circ J; 2009 Sep; 73(9):1612-8. PubMed ID: 19609043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of factors affecting the progression and termination of drug induced Torsade de pointes in two dimensional cardiac tissue.
    Kirthi Priya P; Reddy MR
    J Electrocardiol; 2017; 50(3):332-341. PubMed ID: 28202194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation.
    Daubert JP
    Cardiol J; 2009; 16(6):491-2. PubMed ID: 19950083
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter].
    López Gil M; Arribas F; Hernández Afonso J; Angel Santos M; García-Cosío F
    Rev Esp Cardiol; 1996; 49 Suppl 2():32-41. PubMed ID: 8755694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing.
    Fish JM; Di Diego JM; Nesterenko V; Antzelevitch C
    Circulation; 2004 May; 109(17):2136-42. PubMed ID: 15078801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dynamic electrophysiological examination of heart in patients with sick sinus syndrome in continuous pacing].
    Iskenderov BG; Tatarchenko IP
    Ter Arkh; 1998; 70(4):24-7. PubMed ID: 9612897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical management of atrial fibrillation: future directions.
    Page RL
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S91-4. PubMed ID: 17336894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease.
    D'Aloia A; Faggiano P; Brentana L; Boldini A; Pedrinazzi C; Procopio R; Dei Cas L
    Int J Cardiol; 2005 Dec; 105(3):337-9. PubMed ID: 15985302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.